SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UPDATE: JP Morgan On Teva Also Notes 'However, TEVA's near-to-mid-term fundamentals are stabilizing (unlike some of its peers). Further, mgmt's comments on opioids appear encouraging'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · -